In the last week, the Healthcare Distributors industry is up 7.0%, with YSB up 34%. Meanwhile, Charmacy Pharmaceutical actually underperformed within the industry, shrinking 6.4% in the last week. This means that the industry has gained 23% over the past year. Looking forward, earnings are forecast to grow by 29% annually.
Has the Hong Kong Healthcare Distributors Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 21 Sep 2023 | HK$174.6b | HK$750.7b | HK$9.6b | 11.9x | 18.3x | 0.2x |
Sat, 19 Aug 2023 | HK$173.6b | HK$725.9b | HK$6.6b | 10.1x | 26.5x | 0.2x |
Mon, 17 Jul 2023 | HK$164.7b | HK$738.2b | HK$9.5b | 9x | 17.4x | 0.2x |
Wed, 14 Jun 2023 | HK$157.8b | HK$705.3b | HK$11.0b | 10.5x | 14.3x | 0.2x |
Fri, 12 May 2023 | HK$162.4b | HK$727.4b | HK$11.4b | 10.7x | 14.2x | 0.2x |
Sun, 09 Apr 2023 | HK$159.0b | HK$733.1b | HK$12.1b | 11.1x | 13.1x | 0.2x |
Tue, 07 Mar 2023 | HK$143.9b | HK$714.4b | HK$13.1b | 11x | 11x | 0.2x |
Thu, 02 Feb 2023 | HK$129.1b | HK$734.0b | HK$13.4b | 14x | 9.7x | 0.2x |
Sat, 31 Dec 2022 | HK$125.9b | HK$712.8b | HK$13.0b | 13.4x | 9.7x | 0.2x |
Mon, 28 Nov 2022 | HK$112.5b | HK$687.6b | HK$12.5b | 12.8x | 9x | 0.2x |
Wed, 26 Oct 2022 | HK$58.8b | HK$592.6b | HK$8.1b | 12.9x | 7.2x | 0.1x |
Fri, 23 Sep 2022 | HK$59.6b | HK$610.1b | HK$8.0b | 15.3x | 7.5x | 0.1x |
Sun, 21 Aug 2022 | HK$63.9b | HK$624.0b | HK$8.5b | 13.8x | 7.5x | 0.1x |
Tue, 19 Jul 2022 | HK$70.5b | HK$629.8b | HK$8.6b | 16.8x | 8.2x | 0.1x |
Thu, 16 Jun 2022 | HK$70.0b | HK$631.3b | HK$8.7b | 16.1x | 8x | 0.1x |
Sat, 14 May 2022 | HK$69.4b | HK$618.7b | HK$8.4b | 15.8x | 8.3x | 0.1x |
Mon, 11 Apr 2022 | HK$69.9b | HK$658.7b | HK$9.0b | 16.9x | 7.8x | 0.1x |
Wed, 09 Mar 2022 | HK$69.9b | HK$647.8b | HK$9.2b | 14.5x | 7.6x | 0.1x |
Fri, 04 Feb 2022 | HK$67.7b | HK$641.7b | HK$8.9b | 15.2x | 7.6x | 0.1x |
Sun, 02 Jan 2022 | HK$66.0b | HK$642.9b | HK$9.0b | 17.8x | 7.4x | 0.1x |
Tue, 30 Nov 2021 | HK$69.3b | HK$639.0b | HK$8.9b | 13.8x | 7.8x | 0.1x |
Thu, 28 Oct 2021 | HK$68.9b | HK$638.0b | HK$8.9b | 13x | 7.7x | 0.1x |
Sat, 25 Sep 2021 | HK$73.1b | HK$621.0b | HK$8.8b | 15x | 8.3x | 0.1x |
Mon, 23 Aug 2021 | HK$72.7b | HK$619.7b | HK$8.8b | 16x | 8.2x | 0.1x |
Sat, 10 Jul 2021 | HK$83.1b | HK$619.7b | HK$8.8b | 14.2x | 9.4x | 0.1x |
Fri, 02 Apr 2021 | HK$67.2b | HK$584.1b | HK$8.2b | 11.3x | 8.2x | 0.1x |
Mon, 04 Jan 2021 | HK$66.7b | HK$557.2b | HK$7.7b | 12.2x | 8.7x | 0.1x |
Thu, 08 Oct 2020 | HK$58.6b | HK$516.6b | HK$6.6b | 12.5x | 8.8x | 0.1x |
8.8x
How does Hong Kong Healthcare Distributors compare with similar industries?
HK Market | 0.35% | |
Healthcare | 1.67% | |
Healthcare Services | 3.95% | |
Healthcare Distributors | 9.82% | |
Managed Healthcare | 0% | |
Healthcare Facilities | -3.16% | |
Healthcare Services | -4.29% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1099 Sinopharm Group | HK$22.55 | 5.1% +HK$3.4b | 44.2% | PE7.3x | |
874 Guangzhou Baiyunshan Pharmaceutical Holdings | HK$22.50 | 4.7% +HK$1.6b | 23.2% | PE8.1x | |
9885 YSB | HK$49.00 | 2.0% +HK$602.1m | n/a | PS1.9x | |
1345 Shanghai Pioneer Holding | HK$2.19 | 6.8% +HK$164.8m | -9.1% | PE12.6x | |
6833 Sinco Pharmaceuticals Holdings | HK$0.27 | 12.0% +HK$59.0m | -10.0% | PE18.8x |